BSX
NYSE · Health Care
Boston Scientific Corp
$62.75
-0.18 (-0.29%)
Analyst Consensus
Strong Buy
40
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+117.3% upside
Low Target
$87.61
Average Target
$136.36
High Target
$141.95
Current Price
$62.75
Current
$62.75
$62.75
Target
$136.36
$136.36
$87.61
$136.36 avg
$141.95
Scenario Analysis
Bear Case
$87.61
39.6%
Low target
Base Case
$136.36
+117.3%
Avg target
Bull Case
$141.95
+126.2%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$109.50
-42.7% from high
52-Week Low
$67.56
+-7.1% from low
50-Day SMA
$89.93
-30.2% vs SMA
200-Day SMA
$99.13
-36.7% vs SMA
RSI (14)
21.5
Oversold
Target vs 52W High
$136.36
+24.5% vs high
Next Earnings Report
Apr 22, 2026 · Before Market Open
20d
until earnings
EPS Est: $0.80
Peer Consensus — Health Care
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| UNH | Buy | 34 | 68% | $293.85 | +8.6% |
| ABT | Buy | 35 | 71% | $123.47 | +20.3% |
| ISRG | Buy | 42 | 69% | $219.77 | -52.3% |
| SYK | Strong Buy | 37 | 76% | $338.36 | +3.0% |
| MDT | Buy | 38 | 63% | $192.46 | +122.1% |
| HCA | Buy | 31 | 58% | $118.82 | -74.9% |
| MCK | Strong Buy | 22 | 86% | $307.39 | -64.5% |
| BSX | Strong Buy | 40 | 93% | $136.36 | +117.3% |